EXAS vs JMSB · rev $2.76B vs P/E 13, rev $113.3M
EXACT Sciences Corporation (EXAS) versus John Marshall Bancorp Inc (JMSB) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
John Marshall Bancorp Inc (JMSB) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported JMSB revenue for 2025-12-31 was $113.3M. Net income was $21.2M. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JMSB currently screens at market cap $300.6M and trailing P/E 13.5.
EXAS currently screens at market cap $20.03B. JMSB currently screens at market cap $300.6M and trailing P/E 13.5.
Not investment advice. Open the EXAS and JMSB stock pages for the full models.
Not investment advice.